Fig. 4From: Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver diseaseA–C Activity levels of FVIII, FV, and PS in patients with CLD awaiting LT. D, E FV and PS activity levels with patient-matched FVIII activity levels. Red dots: patients with confirmed PVT within 3 months of enrollment; blue dot: patient with confirmed PVT 25 months prior to enrollmentBack to article page